Showing results (101-110 of 194) with videos related to
Sort By:
Pageof 20
Nature Communications|January 23, 2020
Hepatitis Delta Virus histone mimicry drives the recruitment of chromatin remodelers for viral RNA replicationNatali Abeywickrama-Samarakoon, Jean-Claude Cortay, Camille Sureau, et al.Journal of Hepatology|February 8, 2018
No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cmKayvan Mohkam, Paul-Noël Dumont, Anne-Frédérique Manichon, et al.Journal of Clinical Neuromuscular Disease|May 25, 2017
Cardiac Abnormalities in Type 1 Facioscapulohumeral Muscular DystrophyFabien Labombarda, Maxime Maurice, Jean-Philippe Simon, et al.Frontiers in Immunology|June 28, 2023
Case Report: Successful liver transplantation after achieving complete clinical remission of advanced HCC with Atezolizumab plus Bevacizumab combination therapyYasmina Chouik, Domitille Erard, Hassan Demian, et al.Molecular Biology of the Cell|October 13, 2017
Down-regulation of the Wnt/β-catenin signaling pathway by Cacnb4Mohamad Rima, Marwa Daghsni, Anaïs Lopez, et al.Neurosurgery|February 19, 2014
High-resolution 3-dimensional T2*-weighted angiography (HR 3-D SWAN): an optimized 3-T magnetic resonance imaging sequence for targeting the subthalamic nucleusMichel Lefranc, Stéphane Derrey, Philippe Merle, et al.Journal of Hepatology|August 16, 2005
Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinomaPhilippe Merle, Miran Kim, Marc Herrmann, et al.Gut|May 22, 2021
RNA helicase DDX5 enables STAT1 mRNA translation and interferon signalling in hepatitis B virus replicating hepatocytesJiazeng Sun, Guanhui Wu, Florentin Pastor, et al.Oncotarget|February 18, 2016
Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencingDavide Degli Esposti, Hector Hernandez-Vargas, Catherine Voegele, et al.Vaccine|November 23, 2007
Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudinePierre Vandepapelière, George K K Lau, Geert Leroux-Roels, et al.Pageof 20